Jeanne E Loughlin
Overview
Explore the profile of Jeanne E Loughlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loughlin J, Cole J, Dodd S, Schein J, Thornhill J, Walker A
Pain Med
. 2004 Apr;
3(1):47-55.
PMID: 15102218
Objective: To quantify resource utilization and costs incurred for patients who received transdermal fentanyl as their first long-acting analgesic for non-malignant pain, and to compare these with utilization and costs...
2.
Cole J, Loughlin J, Ajene A, Rosenberg D, Cook S, Walker A
Clin Ther
. 2002 Dec;
24(11):1824-39.
PMID: 12501877
Background: Complications of influenza are a major cause of morbidity and mortality during the influenza season. Clinical trials of zanamivir have reported a reduced incidence of influenza complications among high-risk...
3.
Loughlin J, Alfredson T, Ajene A, Cole J, Cook S, Rosenberg D, et al.
Clin Ther
. 2002 Dec;
24(11):1786-99.
PMID: 12501874
Background: Inhaled zanamivir is indicated for treatment of uncomplicated acute illness due to influenza A and B viruses in patients aged > or = 12 years who have been symptomatic...
4.
Loughlin J, Cole J, Rothman K, Johnson E
Ann Allergy Asthma Immunol
. 2002 Apr;
88(3):319-25.
PMID: 11926627
Background: Some leukotriene receptor antagonists, such as zafirlukast and montelukast, have been associated with systemic eosinophilia, with interest focused on Churg-Strauss syndrome (CSS). Objective: To calculate the background incidence rate...